Tag: haemodialysis

amplifi vein dilation system

Artio Medical completes enrolment of first-in-human trial investigating Amplifi vein dilation...

Artio Medical announced today it has completed enrolment in its first-in-human study evaluating the Amplifi vein dilation system. In the study, five patients were treated...
covid-19 vaccine dialysis patients

Nationwide survey indicates hesitancy among US dialysis patient groups over COVID-19...

A nationwide survey distributed among 150 randomly selected dialysis facilities in the USA has found that a “substantial proportion” of patients receiving in-centre haemodialysis...
PROPr kidney failure score

New scoring system measures health-related quality of life in kidney failure...

Results from a new study support the validity of a score that considers various patient-reported measures and preferences for assessing health-related quality of life,...
quanta dialysis funding

Quanta announces “largest private funding round in history” for a dialysis...

Quanta Dialysis Technologies has announced that it has raised US$245 million in an oversubscribed and upsized Series D financing round—the largest private funding round...
covid-19 vaccine dialysis patients

US Renal Care distributes second round of COVID-19 vaccines to dialysis...

Dialysis provider US Renal Care recently announced it has finished administering a second round of mRNA vaccines to ensure better protection against COVID-19 for...

Arteriovenous fistulas contribute to higher survival of haemodialysis patients with COVID-19

A new study, published online in The Journal of Vascular Access (JVA), suggests that arteriovenous fistulas (AVFs) contribute to higher survival of haemodialysis patients...
theranova dialyser

Baxter reports Theranova dialyser may reduce cardiovascular events and hospitalisations

Baxter International, a global innovator in renal care, has announced new data showing expanded haemodialysis (HDx) therapy enabled by the company's Theranova dialyser may...
Robert Jones in the IR suite

Balloon angioplasty in critical time window central to endovascular success for...

Tackling the main culprit, stenosis in the arteriovenous anastomosis and outflow veins, with balloon angioplasty before it is “too late” can boost maturation rates...
era congress 2021

ERA-EDTA announces name change following late-breaking clinical data at 2021 congress

Fresh evidence on the usefulness of sonography to ease the burden of lung congestion in haemodialysis patients and “promising data” on a long-awaited targeted...
new vascular access technologies

Nitric oxide, simulation and “living” grafts: Is the landscape of vascular...

The field of vascular access care for haemodialysis patients may look very different in just a few years’ time, with a host of new,...
early-cannulation grafts

Early-cannulation grafts display parity with ePTFE options—but also face similar challenges

In addition to demonstrating comparable performance in terms of long-term patency, durability and associated complications, early-cannulation arteriovenous (AV) grafts may hold some advantages when...
baxter international artificial kidney ak 98 dialysis machine

Baxter gains FDA clearance for next-generation AK 98 dialysis machine

American healthcare firm and global renal care innovator Baxter International has announced US Food and Drug Administration (FDA) 510(k) clearance of its next-generation Artificial...

Study supports tunnelled haemodialysis catheter use for permanent dialysis access

In a recent study, Victor Demaerel (University Hospitals Leuven, Leuven, Belgium) and colleagues found that tunnelled haemodialysis catheter (THC) survival in 352 patients was...
sabine nipshagen plastic cannulas

Plastic cannulas offer useful new option in toolbox for renal nurses

Despite currently being less commonly used than metal needles in haemodialysis access, particularly in Europe, plastic cannulas offer a “useful new tool in the...
invizius

Invizius raises £5.3 million to assess anti-inflammatory treatment for haemodialysis patients

Invizius has announced the closing of a Series A financing round worth £5.3 million. The Scottish biotechnology company will use this funding to complete...

Vascular Therapies announces clinical results from phase 3 randomised multicentre clinical...

Vascular Therapies recently announced results from its phase 3 clinical trial in which Sirogen showed encouraging arteriovenous fistula (AVF) outcomes in elderly end-stage renal...

BD announces enrolment in postmarket studies of the WavelinQ endoAVF system

BD announced today that enrolment has begun and the first patients have been treated in the postmarket surveillance study, CONNECT-AV. CONNECT-AV is a prospective, single-arm,...
haemodialysis access spontaneous recanalisation ansar vance

Clotted haemodialysis accesses can spontaneously recanalise following abandonment

Clotted haemodialysis accesses can spontaneously recanalise following a failed thrombectomy and subsequent abandonment, a retrospective review of 3,137 mechanical thrombectomy procedures has found. The...
pristine catheter bd

BD gains FDA 510(k) clearance for Pristine long-term haemodialysis catheter

American medical technology company BD (Becton, Dickinson and Company) has received 510(k) clearance from the US Food and Drug Administration (FDA) for its Pristine...
haemodialysis access strategies mariana murea nephrology professor

Multicentre trial of haemodialysis access strategies in older patients deemed feasible...

A multicentre clinical trial to assess arteriovenous fistula (AVF)-first and arteriovenous graft (AVG)-first access strategies in older end-stage renal disease (ESRD) patients on haemodialysis...
fresenius home dialysis

Fresenius and DaVita make home dialysis technologies available to patients across...

Fresenius Medical Care North America and DaVita Kidney Care have announced an expanded agreement to make multiple home dialysis technologies available for patients across...

ISABELLA trial for the treatment of failing AV fistulas in haemodialysis...

MedAlliance has announced completion of patient enrolment in the ISABELLA clinical trial with the Selution SLR 018 drug-eluting balloon (DEB) for the treatment of...

Tunneled cuffed dialysis catheters: Why does the catheter’s tip matter?

A tunneled catheter remains the most common access in patients initiating haemodialysis.1 This is most likely because the catheters are ready to use immediately...

PatenSee initiates first-in-human trial with its contactless imaging surveillance system for...

PatenSee has initiated a first-in-human clinical trial to assess its machine vision-based surveillance system, a press release from the company reveals. The trial, led...

Medtronic launches IN.PACT AV DCB in Japan for patients undergoing haemodialysis

Medtronic has announced the launch of IN.PACT AV drug-coated balloon (DCB) in Japan. IN.PACT AV DCB is indicated for the treatment of obstructive lesions...